What is INKON Life Technology Co., Ltd.'s (300143.SZ) StockRank?

MoatMap's StockRank for INKON Life Technology Co., Ltd. (300143.SZ) is 38/100, with a Hold signal. This is a composite score combining Quality (53), Value (22), and Momentum (55) factor ranks across MoatMap's 20,000+ stock universe.

Does INKON Life Technology Co., Ltd. have an economic moat?

INKON Life Technology Co., Ltd. (300143.SZ) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is INKON Life Technology Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for INKON Life Technology Co., Ltd. (300143.SZ) is Hold, based on a StockRank of 38/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is INKON Life Technology Co., Ltd. in?

INKON Life Technology Co., Ltd. (300143.SZ) operates in the Healthcare sector, specifically the Medical Devices industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300143.SZ

HOLDREMOVE

INKON Life Technology Co., Ltd. · Healthcare · China · $1.1B · Avg Vol: $11M/d

StockRank

P/E (TTM)

99.3x

ROE

3.4%

D/E

0.3x

Dividend %

0.3%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

A Chinese medical equipment and hospital management company. It faces severe domestic regulatory headwinds, centralized procurement price cuts, and lacks a global competitive moat.

COMPANY DESCRIPTION

INKON Life Technology Co., Ltd. provides medical devices and healthcare services, specializing in oncology diagnosis and treatment equipment, such as stereotactic radiotherapy systems. The company operates a dual-engine business model combining high-end medical equipment manufacturing with oncology hospital management. Its competitive advantage lies in its proprietary medical imaging and radiotherapy technologies, alongside a growing network of specialized healthcare facilities in China.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	171M	217M	230M	279M	17.7%
EPS	-0.15	0.02	0.03	0.01	-25.0%
Shares	642M	642M	749M	749M	+16.7%
Debt	17M	44M	50M	114M	88.8%
Equity	190M	204M	359M	371M	25.1%
Op CF	24M	28M	38M	50M	28.5%
Inv CF	-61M	-40M	-65M	-99M	—
Fin CF	3M	18M	139M	25M	—

PRICE (1M)-39.0%

SMA 50SMA 200

$1.02

RSI (14)

21.4

52W High

$1.63

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

5.2%57.4

ROE

3.4%52.2

GP/Assets

12.4%30.6

Op. Margin

8.7%63.0

FCF/Assets

2.9%61.7

Piotroski

—83.4

Int. Cover

8.7x62.4

D/E Ratio

0.28x44.8

Current Ratio

2.21x41.7

Value

P/E (TTM)

99.3x9.3

EV/EBITDA

23.8x15.2

P/FCF

420.3x20.0

P/B

2.6x44.8

P/S

3.4x52.5

Div Yield

0.3%7.3

Momentum

52W High %

63%45.2

RS 6M

-20%57.3

SMA 50/200

0.98x56.6

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—90.9

Q Growth

-14%29.2

FUNDAMENTALS

Market Cap

$1.1B

P/E (Forward)

27.8x

Gross Margin

26.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300143.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300143.SZ	INKON Life Technology Co., Ltd.(you)	$1.1B	38	HOLD
600055.SS	Beijing Wandong Medical Technology Co.,Ltd.	$1.3B	37	HOLD
688108.SS	Sino Medical Sciences Technology Inc.	$1.4B	36	HOLD
688161.SS	Shandong Weigao Orthopaedic Device Co., Ltd	$1.6B	39	HOLD
688198.SS	Beijing Balance Medical Technology Co.,Ltd.	$1.7B	39	HOLD
300633.SZ	SonoScape Medical Corp.	$1.3B	28	SELL
300298.SZ	Sinocare Inc.	$1.3B	48	HOLD
688298.SS	Zhejiang Orient Gene Biotech Co., Ltd	$638M	42	HOLD
1609.HK	Star Sports Medicine Co., Ltd.	$1.4B	26	SELL
688575.SS	Shenzhen YHLO Biotech Co., Ltd.	$870M	26	SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

INKON Life Technology Co., Ltd. (300143.SZ) — Stock Score Summary

INKON Life Technology Co., Ltd. (300143.SZ) has a MoatMap StockRank of 38/100 based on Quality (53/100), Value (22/100), and Momentum (55/100) factor scores. The current signal is HOLD. A Chinese medical equipment and hospital management company. It faces severe domestic regulatory headwinds, centralized procurement price cuts, and lacks a global competitive moat.

Key Financial Metrics

Price	$1.02
Market Cap	$1.1B
P/E (TTM)	99.29
P/E (Forward)	27.80
Price/Book	2.65
Return on Equity	3.4%
Return on Invested Capital	5.2%
Debt/Equity	28.34
Gross Margin	26.3%
Operating Margin	8.7%
Revenue Growth	21.4%
Dividend Yield	0.3%
Free Cash Flow	$3M

INKON Life Technology Co., Ltd. operates in the Medical Devices industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is INKON Life Technology Co., Ltd.’s (300143.SZ) StockRank?: MoatMap’s StockRank for INKON Life Technology Co., Ltd. (300143.SZ) is 38/100, with a Hold signal. It is a composite of Quality (53), Value (22), and Momentum (55) factor ranks across MoatMap’s 20,000+ stock universe.
Does INKON Life Technology Co., Ltd. have an economic moat?: INKON Life Technology Co., Ltd. (300143.SZ) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is INKON Life Technology Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for INKON Life Technology Co., Ltd. (300143.SZ) is Hold, based on a StockRank of 38/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is INKON Life Technology Co., Ltd. in?: INKON Life Technology Co., Ltd. (300143.SZ) operates in the Healthcare sector, specifically the Medical Devices industry (China).